Unity Biotechnology, Inc.UBXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-21.9%
5Y CAGR-21.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-21.9%/yr
vs +5.7%/yr prior
5Y CAGR
-21.1%/yr
Consistent
Acceleration
-27.6pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $27.86M | +11.6% |
| 2023 | $24.97M | +11.7% |
| 2022 | $22.35M | -61.8% |
| 2021 | $58.57M | -33.4% |
| 2020 | $87.89M | -3.4% |
| 2019 | $91.00M | +21.5% |
| 2018 | $74.92M | +59.4% |
| 2017 | $46.99M | +149.4% |
| 2016 | $18.84M | - |